These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 714890)

  • 1. [Treatment procedures in myelofibrosis].
    Klimova NF
    Probl Gematol Pereliv Krovi; 1978; 23(11):31-5. PubMed ID: 714890
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormones in cancer chemotherapy.
    Kennedy BJ
    Proc Natl Cancer Conf; 1970; 6():627-32. PubMed ID: 5458126
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis.
    Benetatos L; Chaidos A; Alymara V; Vassou A; Bourantas KL
    Eur J Haematol; 2005 Mar; 74(3):273-4. PubMed ID: 15693801
    [No Abstract]   [Full Text] [Related]  

  • 4. Agnogenic myeloid metaplasia. Natural history and treatment.
    Silverstein MN; Gomes MR; ReMine WH; Elveback LR
    Arch Intern Med; 1967 Nov; 120(5):546-50. PubMed ID: 6054588
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical picture and pathogenesis of osteomyelosclerosis].
    Müller D
    Dtsch Med Wochenschr; 1970 Mar; 95(12):643-8. PubMed ID: 4915274
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tactics of cytostatic therapy of primary and secondary (post-erythremic) myelofibrosis].
    Demidova AV; Sysoeva NA
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):23-7. PubMed ID: 1071792
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
    Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
    Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current therapeutic possibilities in idiopathic myelofibrosis. Observations on 47 cases].
    Perugini S; Ascari E; Fontana G
    Clin Ter; 1968 Apr; 45(1):21-60. PubMed ID: 4897957
    [No Abstract]   [Full Text] [Related]  

  • 11. [Onset of polycythemia in idiopathic myelofibrosis. Description of a clinical case and review of the literature].
    Pagano L; Teofili L; Marra R; Storti S; Rabbitti C; Leone G; Bizzi B
    Minerva Med; 1988 Jan; 79(1):51-4. PubMed ID: 3277085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The hormone and chemotherapy in female metastatic breast cancer (author's transl)].
    Obrecht JP; Nagel GA; Mayr AC
    Schweiz Rundsch Med Prax; 1974 Jan; 63(4):109-14. PubMed ID: 4411163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis].
    Engelmann C; Schulz K; Nowotny P; Konrad H
    Dtsch Gesundheitsw; 1972 Dec; 27(50):2375-80. PubMed ID: 4651200
    [No Abstract]   [Full Text] [Related]  

  • 14. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone].
    Tanosaki R; Uchida H; Masuda Y; Michikawa N; Ogawa T; Kubo A; Ikeda Y
    Rinsho Ketsueki; 1992 Feb; 33(2):256-8. PubMed ID: 1635179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis].
    Takahari D; Matsunaga T; Fujimi A; Kikuchi T; Seki R; Tanaka I; Takemoto N; Akiyama T; Sato T; Terui T; Kogawa K; Kato J; Kura T; Maeda T; Niitsu Y
    Rinsho Ketsueki; 2002 Oct; 43(10):924-30. PubMed ID: 12462028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The onset of a refractory response to androgens in the anemia of bone marrow failure.
    Gardner FH; Besa EC
    Trans Am Clin Climatol Assoc; 1977; 88():108-18. PubMed ID: 898530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus presenting with myelofibrosis.
    Foley-Nolan D; Martin MF; Rowbotham D; McVerry A; Gooi HC
    J Rheumatol; 1992 Aug; 19(8):1303-4. PubMed ID: 1404171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alkylating agents on hematopoiesis in myelofibrosis. 4 case report.
    Charbord P; Neel H; Caillou B; Kahn E; Parmentier C
    Nouv Rev Fr Hematol (1978); 1984; 26(6):361-9. PubMed ID: 6527942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K; Zák P
    Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.